Skip to content

Safety Evaluation of Advantage Anti-Caries Varnish

Phase 1 Safety Evaluation of Advantage Anti-Caries Varnish

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02645617
Enrollment
12
Registered
2016-01-05
Start date
2016-03-30
Completion date
2016-10-20
Last updated
2020-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries

Brief summary

The purpose of the study is to confirm the safety of Advantage Anti-Caries Varnish.

Detailed description

This is an open-label Phase 1 study. The active ingredients are Povidone Iodine and Sodium Fluoride \[Therametrics Technologies, Inc, Noblesville, IN, USA\]. The oral soft tissues and teeth of the children will be examined and the test varnish to the teeth. The child will be re-examined at 24-48 hours for the presence of adverse oral soft tissue changes. At the follow-up, a qualified dental provider will ask questions focused on adverse events.

Interventions

Topical application to the teeth

Sponsors

Advantage Dental Services, LLC
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
36 Months to 60 Months
Healthy volunteers
Yes

Inclusion criteria

* Healthy

Exclusion criteria

* Weight less than 15 kg or hypersensitivity to iodine

Design outcomes

Primary

MeasureTime frameDescription
Soft Tissuewithin 48 hoursProportion of participants with any oral ulcerations OR inflammatory response

Secondary

MeasureTime frameDescription
Adverse Eventswithin 48 hoursProportion of participants with any emergency medical care OR report of nausea OR not eating OR vomiting OR difficulty swallowing OR swelling around the mouth OR itchiness around the mouth OR hives OR rash OR stomach ache OR diarrhea

Countries

United States

Participant flow

Participants by arm

ArmCount
Varnish
Dental varnish containing povidone iodine and sodium fluoride Varnish: Topical application to the teeth
12
Total12

Baseline characteristics

CharacteristicVarnish
Age, Categorical
<=18 years
12 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
8 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
2 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
Race (NIH/OMB)
White
5 Participants
Region of Enrollment
United States
12 participants
Sex: Female, Male
Female
6 Participants
Sex: Female, Male
Male
6 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 12
other
Total, other adverse events
0 / 12
serious
Total, serious adverse events
0 / 12

Outcome results

Primary

Soft Tissue

Proportion of participants with any oral ulcerations OR inflammatory response

Time frame: within 48 hours

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
VarnishSoft Tissue0 Participants
Secondary

Adverse Events

Proportion of participants with any emergency medical care OR report of nausea OR not eating OR vomiting OR difficulty swallowing OR swelling around the mouth OR itchiness around the mouth OR hives OR rash OR stomach ache OR diarrhea

Time frame: within 48 hours

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
VarnishAdverse Events0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026